Interactive Transcript
0:00
So this first one was a case of radiation changes following
0:05
treatment for radiation therapy. I believe this section was on larynx,
0:10
I believe, if I, if I recall. Mm-hmm. So, um,
0:13
this first case was an example of a patient that had an early true vocal cord
0:17
carcinoma. It's hard to see actually on the pre-treatment study,
0:21
but when we look at the post-treatment study,
0:23
what we end up seeing is diffuse thickening involving
0:28
the, uh,
0:29
true vocal cords and diffuse thickening involving the bilateral area
0:34
epiglottic fos.
0:35
So one thing that's a little bit unusual is because it's a left true vocal cord
0:40
carcinoma,
0:40
they gave a little bit more radiation therapy on the left than on the right. Um,
0:46
the, the attenuation here is actually low attenuation,
0:49
so there's really no aggressive mass seen. Um,
0:53
obviously you can't di differentiate between recurrent tumor,
0:58
uh, microscopic recurrent tumor and just post-treatment changes.
1:02
So I think if you did say you should always in your report say you can't exclude
1:06
microscopic disease, but these findings are pretty much consistent with,
1:11
um, post-treatment changes. So,
1:15
you know what I wanted to do and um, lemme see if I could bring this up here.
1:20
So following radiation therapy,
1:23
what ends up happening is that the radiation therapy elicits an acute
1:27
inflammatory response and this lasts typically about 24 hours.
1:31
And this is followed by interstitial edema. So after you give radiation therapy,
1:35
there's a lot of edema. There's also disruption in the blood vessels, um,
1:40
and the lymphatics.
1:42
And in approximately four weeks you end up developing fibrosis and this involves
1:46
the connective tissues, the blood vessels, and the lymphatics.
1:49
And oftentimes patients are treated with radiation therapy and chemotherapy.
1:54
So what the chemotherapy does is just, it just sort of exacerbates the changes.
1:59
So on the left here is a pre-treatment image and on the right here is
2:02
post-treatment.
2:04
And you can see after post-treatment you can see skin thickening.
2:07
We can see thickening of the platysma muscle,
2:10
we can see thickening here of the strap muscles.
2:13
Notice the radiation changes and thickening involved in the submandibular
2:17
glands. Here's one area epiglottic fold. Here's the other area. Epiglottic fold.
2:21
See how they're diffusely thickened in their symmetric bilaterally.
2:24
And we can see thickening of the posterior pharyngeal wall and we can see edema
2:28
involving the retro pharyngeal space. Another example here,
2:33
pre-treatment, we can see the free margin of the epiglottis.
2:36
After we give radiation therapy,
2:38
we can see diffuse thickening of the epiglottis and notice a low attenuation
2:42
here. There's low attenuation here and that's more indicative of post-treatment
2:45
changes. Also, look at the submandibular glands.
2:48
We can see that they're thickened, or excuse me,
2:51
they're actually in this case shrunken.
2:53
We can see skin thickening here and reticulation of the subcutaneous fat.
2:57
And look at the thickening of the patal muscle two and compare that to the
3:01
pre-treatment studies. Again,
3:05
pre-treatment versus post-treatment.
3:07
These are those changes that you expect to see.
3:09
We see the diffuse skin thickening, we can see the low attenuation.
3:12
And one of the key things that we look for is, uh, sym symmetry.
3:18
Now what about response? So here's example of what we would like to see.
3:22
So here is a pre-treatment image, a large mass here,
3:25
and we can see complete results after radiation therapy.
3:29
Another example here, d uh,
3:31
large mass here involving the left vem after radiation therapy.
3:35
Look at all the changes here. Diffuse thickening of the free margin,
3:38
the epiglottic colotti thickening of the median gloss of epiglottic fold.
3:44
We can see the radiation sil adenitis, uh,
3:47
characterized by decrease in size of the submandibular glands and,
3:51
and abnormal enhancement.
3:53
So the things that we look for after radiation therapy is that what we would
3:58
like to see is a situation like this where we have a mass on the right side and
4:02
after radiation therapy we see complete resolution.
4:05
See how it's completely shrunk. In this particular case, pre-treatment,
4:09
post-treatment, we still see this persistent mass.
4:12
So what we look for is that another example here,
4:16
this is an example of pre-treatment and after treatment we can still see this
4:21
residual focal enhancing mass. So the way the,
4:24
what we would like to see is either complete resolution such as this
4:29
and it completely vanished.
4:31
Or what we end up looking for is a persistent soft tissue mass in which
4:36
the tumor has not reduced by greater than 50%.
4:40
So those are the things that we look for, um, uh, in order to look to,
4:45
to look at complete response. I think the challenge, um,
4:48
in this case was, uh, because there was a left sided tumor,
4:53
a lot of the patients now are getting higher doses to the side of the tumor.
4:57
So we do see the typical changes where we see the low attenuation.
5:00
It's a little bit thicker on the left than on the right,
5:03
but in general we don't see a, a bulky mass here.
5:06
Rather we see all these changes that we would typically expect to see after
5:10
radiation therapy.
5:12
So let me stop there and do you have any questions at all for that?
5:15
So actually, if we don't have any previous image, we have to look for any,
5:21
if any obvious enhancement, you'll be the recurrence or residue disease.
5:26
If not, if we see any low ation will be just edema for the radiation.
5:32
Yeah, it's more indicative.
5:33
So specifically what we look for is an enlarging mass at the primary site or
5:37
along the margin. So that's the one thing that we look for. And, and,
5:41
and enlarging, if we see a big mass pre-treatment,
5:44
we want to see if that mass completely resolves.
5:47
If there is a lower volume lesion and then after radiation therapy the mass
5:51
starts to up, there's a, a, a mass that's growing at the site of the treatment,
5:57
then that's more that's indicative of recurrent tumor.
6:00
The other thing that we always have to look for too is we also want to evaluate
6:04
the lymph nodes because sometimes you'll see nothing at the
6:08
primary site. But then once we look, uh, more in the neck,
6:13
sometimes we'll have recurrences involving the the, um,
6:17
we will have nodal metastases.